Lumefantrine

CAS No. 82186-77-4

Lumefantrine ( Benflumetol; CPG-56695 )

Catalog No. M16056 CAS No. 82186-77-4

Lumefantrine (or benflumetol) is an antimalarial drug. It is only used incombination with artemether.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 48 In Stock
50MG 65 In Stock
100MG 91 In Stock
200MG 115 In Stock
500MG 178 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lumefantrine
  • Note
    Research use only, not for human use.
  • Brief Description
    Lumefantrine (or benflumetol) is an antimalarial drug. It is only used incombination with artemether.
  • Description
    Lumefantrine (or benflumetol) is an antimalarial drug. It is only used incombination with artemether.
  • Synonyms
    Benflumetol; CPG-56695
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Antiparasitic
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    82186-77-4
  • Formula Weight
    528.94
  • Molecular Formula
    C30H32Cl3NO
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)C(=CC4=CC=C(C=C4)Cl)C2=CC(=C1)Cl)O
  • Chemical Name
    2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ndounga M, et al.Malar J. 2015 Oct 29;14(1):423.
molnova catalog
related products
  • Ezatiostat hydrochlo...

    Ezatiostat hydrochloride is an effective inhibitor of glutathione S-transferase. Ezatiostat hydrochloride is a novel glutathione analog and the potential treatment of cytopenias.

  • Diacetazotol

    Diacetazotol has activity against dioxin-induced ethoxyisochromamide-O-deethylase (EROD,IC50 = 75±4 nM).

  • Atezolizumab

    Atezolizumab anti-PD-L1) is a fully humanized IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1 but not the interaction of PD-L2 with PD-1.